These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 32523653)

  • 1. Amplifications of stemness genes and the capacity of breast tumors for metastasis.
    Litviakov N; Ibragimova M; Tsyganov M; Kazantseva P; Deryusheva I; Pevzner A; Doroshenko A; Garbukov E; Tarabanovskaya N; Slonimskaya E
    Oncotarget; 2020 May; 11(21):1988-2001. PubMed ID: 32523653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amplifications of Stemness Gene Loci-New Markers for the Determination of the Need for Neoadjuvant Chemotherapy for Patients with Breast Cancer. A Prospective Study.
    Litviakov NV; Ibragimova MK; Tsyganov MM; Kazantseva PV; Doroshenko AV; Garbukov EY; Frolova IG; Slonimskaya EM
    J Pers Med; 2021 May; 11(5):. PubMed ID: 34064798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast tumour cell subpopulations with expression of the MYC and OCT4 proteins.
    Litviakov NV; Bychkov VA; Stakheeva MN; Ibragimova MK; Tsyganov MM; Gaptulbarova KA; Tashireva LA; Bondar LN; Garbukov EY; Slonimskaya EM
    J Mol Histol; 2020 Dec; 51(6):717-728. PubMed ID: 33037978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD24+CD44+CD54+EpCAM+ gastric cancer stem cells predict tumor progression and metastasis: clinical and experimental evidence.
    Gómez-Gallegos AA; Ramírez-Vidal L; Becerril-Rico J; Pérez-Islas E; Hernandez-Peralta ZJ; Toledo-Guzmán ME; García-Carrancá A; Langley E; Hernández-Guerrero A; López-Casillas F; Herrera-Goepfert R; Oñate-Ocaña LF; Ortiz-Sánchez E
    Stem Cell Res Ther; 2023 Feb; 14(1):16. PubMed ID: 36737794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neoadjuvant Chemotherapy Induces the Appearance of New Copy Number Aberrations in Breast Tumor and is Associated with Metastasis.
    Litviakov NV; Ibragimova MK; Tsyganov MM; Doroshenko AV; Garbukov EY; Slonimskaya EM
    Curr Cancer Drug Targets; 2020; 20(9):681-688. PubMed ID: 31577208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TGFβ1 Promotes Breast Cancer Local Invasion and Liver Metastasis by Increasing the CD44
    Zhang C; Gao H; Li C; Tu J; Chen Z; Su W; Geng X; Chen X; Wang J; Pan W
    Technol Cancer Res Treat; 2018 Jan; 17():1533033818764497. PubMed ID: 29658391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SLUG/SNAI2 and tumor necrosis factor generate breast cells with CD44+/CD24- phenotype.
    Bhat-Nakshatri P; Appaiah H; Ballas C; Pick-Franke P; Goulet R; Badve S; Srour EF; Nakshatri H
    BMC Cancer; 2010 Aug; 10():411. PubMed ID: 20691079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polyphenols from marine brown algae target radiotherapy-coordinated EMT and stemness-maintenance in residual pancreatic cancer.
    Aravindan S; Ramraj SK; Somasundaram ST; Herman TS; Aravindan N
    Stem Cell Res Ther; 2015 Sep; 6(1):182. PubMed ID: 26395574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BRD4/nuclear PD-L1/RelB circuit is involved in the stemness of breast cancer cells.
    Kim SL; Choi HS; Lee DS
    Cell Commun Signal; 2023 Nov; 21(1):315. PubMed ID: 37924094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lgr5+CD44+EpCAM+ Strictly Defines Cancer Stem Cells in Human Colorectal Cancer.
    Leng Z; Xia Q; Chen J; Li Y; Xu J; Zhao E; Zheng H; Ai W; Dong J
    Cell Physiol Biochem; 2018; 46(2):860-872. PubMed ID: 29627827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p97/VCP is highly expressed in the stem-like cells of breast cancer and controls cancer stemness partly through the unfolded protein response.
    Li C; Huang Y; Fan Q; Quan H; Dong Y; Nie M; Wang J; Xie F; Ji J; Zhou L; Zheng Z; Wang L
    Cell Death Dis; 2021 Mar; 12(4):286. PubMed ID: 33731668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic profiling of different phenotypic subsets of breast cancer stem cells (BCSCs) in breast cancer patients.
    Zekri AN; Bahnassy A; Mourad M; Malash I; Ahmed O; Abdellateif MS
    Cancer Cell Int; 2022 Dec; 22(1):423. PubMed ID: 36585652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mammospheres of letrozole-resistant breast cancer cells enhance breast cancer aggressiveness.
    Patel JR; Gallegos KM; Walker RR; Davidson AM; Davenport I; Tilghman SL
    Oncol Lett; 2021 Aug; 22(2):620. PubMed ID: 34267813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metformin-induced preferential killing of breast cancer initiating CD44+CD24-/low cells is sufficient to overcome primary resistance to trastuzumab in HER2+ human breast cancer xenografts.
    Cufi S; Corominas-Faja B; Vazquez-Martin A; Oliveras-Ferraros C; Dorca J; Bosch-Barrera J; Martin-Castillo B; Menendez JA
    Oncotarget; 2012 Apr; 3(4):395-8. PubMed ID: 22565037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a stemness-related gene panel associated with BET inhibition in triple negative breast cancer.
    Serrano-Oviedo L; Nuncia-Cantarero M; Morcillo-Garcia S; Nieto-Jimenez C; Burgos M; Corrales-Sanchez V; Perez-Peña J; Győrffy B; Ocaña A; Galán-Moya EM
    Cell Oncol (Dordr); 2020 Jun; 43(3):431-444. PubMed ID: 32166583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of mammosphere formation from stem-like cells of normal breast, malignant primary breast tumors, and MCF-7 cell line.
    Ambrose JM; Veeraraghavan VP; Vennila R; Rupert S; Sathyanesan J; Meenakshisundaram R; Selvaraj S; Malayaperumal S; Kullappan M; Dorairaj S; Gujarathi JR; Gandhamaneni SH; Surapaneni KM
    J Egypt Natl Canc Inst; 2022 Dec; 34(1):51. PubMed ID: 36504339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are CD44
    Ryspayeva DE; Smolanka II; Dudnichenko АS; Lyashenko AA; Grinevich YA; Gurianov VG; Koshubarova MV; Seleznev AA
    Exp Oncol; 2017 Sep; 39(3):224-228. PubMed ID: 28967636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the stemness potency of
    Yousefnia S; Ghaedi K; Seyed Forootan F; Nasr Esfahani MH
    Tumour Biol; 2019 Aug; 41(8):1010428319869101. PubMed ID: 31423948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-metastasis activity of curcumin against breast cancer via the inhibition of stem cell-like properties and EMT.
    Hu C; Li M; Guo T; Wang S; Huang W; Yang K; Liao Z; Wang J; Zhang F; Wang H
    Phytomedicine; 2019 May; 58():152740. PubMed ID: 31005718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ANTXR1, a stem cell-enriched functional biomarker, connects collagen signaling to cancer stem-like cells and metastasis in breast cancer.
    Chen D; Bhat-Nakshatri P; Goswami C; Badve S; Nakshatri H
    Cancer Res; 2013 Sep; 73(18):5821-33. PubMed ID: 23832666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.